{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T17:58:12Z","timestamp":1759514292131},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,6,20]],"date-time":"2010-06-20T00:00:00Z","timestamp":1276992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s00223-010-9390-z","type":"journal-article","created":{"date-parts":[[2010,6,21]],"date-time":"2010-06-21T00:21:03Z","timestamp":1277079663000},"page":"263-272","source":"Crossref","is-referenced-by-count":23,"title":["Anabolic and Antiresorptive Drugs Improve Trabecular Microarchitecture and Reduce Fracture Risk following Radiation Therapy"],"prefix":"10.1007","volume":"87","author":[{"given":"Sarah A.","family":"Arrington","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica R.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon E.","family":"Willick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth A.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,20]]},"reference":[{"key":"9390_CR1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1634\/theoncologist.11-3-227","volume":"11","author":"M Clemons","year":"2006","unstructured":"Clemons M, Dranitsaris G, Cole D, Gainford MC (2006) Too much, too little, too late to start again? Assessing the efficacy of bisphosphonates in patients with bone metastases from breast cancer. Oncologist 11:227\u2013233","journal-title":"Oncologist"},{"key":"9390_CR2","first-page":"18","volume":"19","author":"TA Guise","year":"1998","unstructured":"Guise TA, Mundy GR (1998) Cancer and bone. Endocr Rev 19:18\u201354","journal-title":"Endocr Rev"},{"key":"9390_CR3","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y","volume":"88 Suppl 12","author":"TA Guise","year":"2000","unstructured":"Guise TA (2000) Molecular mechanisms of osteolytic bone metastases. Cancer 88 Suppl 12:2892\u20132898","journal-title":"Cancer"},{"key":"9390_CR4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/jnci\/95.3.222","volume":"95","author":"WB Hout van den","year":"2003","unstructured":"van den Hout WB, van der Linden YM, Steenland E, Wiggenraad RG, Kievit J, de Haes H, Leer JW (2003) Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost\u2013utility analysis based on a randomized trial. J Natl Cancer Inst 95:222\u2013229","journal-title":"J Natl Cancer Inst"},{"key":"9390_CR5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/AJP.0b013e3181b0c82c","volume":"26","author":"T Nomiya","year":"2010","unstructured":"Nomiya T, Teruyama K, Wada H, Nemoto K (2010) Time course of pain relief in patients treated with radiotherapy for cancer pain: a prospective study. Clin J Pain 26:38\u201342","journal-title":"Clin J Pain"},{"key":"9390_CR6","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0360-3016(98)00264-8","volume":"42","author":"G Arcangeli","year":"1998","unstructured":"Arcangeli G, Giovinazzo G, Saracino B, D\u2019Angelo L, Giannarelli D, Arcangeli G, Micheli A (1998) Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration. Int J Radiat Oncol Biol Phys 42:1119\u20131126","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9390_CR7","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.ijrobp.2004.05.053","volume":"60","author":"A Konski","year":"2004","unstructured":"Konski A (2004) Radiotherapy is a cost-effective palliative treatment for patients with bone metastasis from prostate cancer. Int J Radiat Oncol Biol Phys 60:1373\u20131378","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9390_CR8","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/jor.1100090614","volume":"9","author":"RK Brown","year":"1991","unstructured":"Brown RK, Pelker RR, Friedlaender GE, Peschel RE, Panjabi MM (1991) Postfracture irradiation effects on the biomechanical and histologic parameters of fracture healing. J Orthop Res 9:876\u2013882","journal-title":"J Orthop Res"},{"key":"9390_CR9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00003086-199708000-00038","volume":"341","author":"RR Pelker","year":"1997","unstructured":"Pelker RR, Friedlaender GE (1997) The Nicolas Andry Award 1995. Fracture healing. Radiation induced alterations. Clin Orthop Relat Res 341:267\u2013282","journal-title":"Clin Orthop Relat Res"},{"key":"9390_CR10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3928\/0147-7447-19880201-15","volume":"11","author":"JD Ackman","year":"1988","unstructured":"Ackman JD, Rouse L, Johnston CE II (1988) Radiation induced physeal injury. Orthopedics 11:343\u2013349","journal-title":"Orthopedics"},{"key":"9390_CR11","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2106\/00004623-200307000-00017","volume":"85-A","author":"TA Damron","year":"2003","unstructured":"Damron TA, Margulies BS, Strauss JA, O\u2019Hara K, Spadaro JA, Farnum CE (2003) Sequential histomorphometric analysis of the growth plate following irradiation with and without radioprotection. J Bone Joint Surg Am 85-A:1302\u20131313","journal-title":"J Bone Joint Surg Am"},{"key":"9390_CR12","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1148\/radiographics.18.5.9747611","volume":"18","author":"MJ Mitchell","year":"1998","unstructured":"Mitchell MJ, Logan PM (1998) Radiation-induced changes in bone. Radiographics 18:1125\u20131136","journal-title":"Radiographics"},{"key":"9390_CR13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/ctrv.2002.0254","volume":"28","author":"BA Jereczek-Fossa","year":"2002","unstructured":"Jereczek-Fossa BA, Orecchia R (2002) Radiotherapy-induced mandibular bone complications. Cancer Treat Rev 28:65\u201374","journal-title":"Cancer Treat Rev"},{"key":"9390_CR14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s12094-007-0098-0","volume":"9","author":"C Conill","year":"2007","unstructured":"Conill C, Tom\u00e1s X, Combalia-Aleu A, Palac\u00edn A, Planas I, Maurel J (2007) Pathological femur fracture secondary to radiation therapy for soft tissue sarcoma. Clin Transl Oncol 9:537\u2013539","journal-title":"Clin Transl Oncol"},{"key":"9390_CR15","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.ijrobp.2008.12.006","volume":"75","author":"CI Dickie","year":"2009","unstructured":"Dickie CI, Parent AL, Griffin AM, Fung S, Chung PW, Catton CN, Ferguson PC, Wunder JS, Bell RS, Sharpe MB, O\u2019Sullivan B (2009) Bone fractures following external beam radiotherapy and limb-preservation surgery for lower extremity soft tissue sarcoma: relationship to irradiated bone length, volume, tumor location and dose. Int J Radiat Oncol Biol Phys 75:1119\u20131124","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9390_CR16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/01.blo.0000229315.58878.c1","volume":"450","author":"M Shaheen","year":"2006","unstructured":"Shaheen M, Deheshi BM, Riad S, Werier J, Holt GE, Ferguson PC, Wunder JS (2006) Prognosis of radiation-induced bone sarcoma is similar to primary osteosarcoma. Clin Orthop Relat Res 450:76\u201381","journal-title":"Clin Orthop Relat Res"},{"key":"9390_CR17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1471-2407-5-89","volume":"5","author":"W Liauw","year":"2005","unstructured":"Liauw W, Segelov E, Lih A, Dunleavy R, Links M, Ward R (2005) Off-trial evaluation of bisphosphonates in patients with metastatic breast cancer. BMC Cancer 5:89","journal-title":"BMC Cancer"},{"key":"9390_CR18","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00520-005-0913-5","volume":"14","author":"JJ Body","year":"2006","unstructured":"Body JJ (2006) Bisphosphonates for malignancy-related bone disease: current status, future developments. Support Care Cancer 14:408\u2013418","journal-title":"Support Care Cancer"},{"key":"9390_CR19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3816\/CBC.2000.n.003","volume":"1","author":"IJ Diel","year":"2000","unstructured":"Diel IJ, Solomayer EF, Bastert G (2000) Treatment of metastatic bone disease in breast cancer: bisphosphonates. Clin Breast Cancer 1:43\u201351","journal-title":"Clin Breast Cancer"},{"key":"9390_CR20","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1200\/JCO.2005.05.116","volume":"23","author":"N Kohno","year":"2005","unstructured":"Kohno N, Aogi K, Minami H, Nakamura S, Asaga T, Iino Y, Watanabe T, Goessl C, Ohashi Y, Takashima S (2005) Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial. J Clin Oncol 23:3314\u20133321","journal-title":"J Clin Oncol"},{"key":"9390_CR21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bone.2005.09.013","volume":"38","author":"SA Arrington","year":"2006","unstructured":"Arrington SA, Schoonmaker JE, Damron TA, Mann KA, Allen MJ (2006) Temporal changes in bone mass and mechanical properties in a murine model of tumor osteolysis. Bone 38:359\u2013367","journal-title":"Bone"},{"key":"9390_CR22","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/jso.20949","volume":"97","author":"SA Arrington","year":"2008","unstructured":"Arrington SA, Damron TA, Mann KA, Allen MJ (2008) Concurrent administration of zoledronic acid and irradiation leads to improved bone density, biomechanical strength, and microarchitecture in a mouse model of tumor-induced osteolysis. J Surg Oncol 97:284\u2013290","journal-title":"J Surg Oncol"},{"key":"9390_CR23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1742-7843.2004.pto940602.x","volume":"94","author":"KT Brixen","year":"2004","unstructured":"Brixen KT, Christensen PM, Ejersted C, Langdahl BL (2004) Teriparatide (biosynthetic human parathyroid hormone 1\u201334): a new paradigm in the treatment of osteoporosis. Basic Clin Pharmacol Toxicol 94:260\u2013270","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"9390_CR24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11154-006-9007-z","volume":"7","author":"M Girotra","year":"2006","unstructured":"Girotra M, Rubin MR, Bilezikian JP (2006) The use of parathyroid hormone in the treatment of osteoporosis. Rev Endocr Metab Disord 7:113\u2013121","journal-title":"Rev Endocr Metab Disord"},{"key":"9390_CR25","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00223-009-9299-6","volume":"85","author":"BL Langdahl","year":"2009","unstructured":"Langdahl BL, Rajzbaum G, Jakob F, Karras D, Ljunggren O, Lems WF, Fahrleitner-Pammer A, Walsh JB, Barker C, Kutahov A, Marin F (2009) Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS). Calcif Tissue Int 85:484\u2013493","journal-title":"Calcif Tissue Int"},{"key":"9390_CR26","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1359\/jbmr.2001.16.8.1486","volume":"16","author":"T Yoneda","year":"2001","unstructured":"Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R (2001) A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 16:1486\u20131495","journal-title":"J Bone Miner Res"},{"key":"9390_CR27","first-page":"2940","volume":"63","author":"KL Weber","year":"2003","unstructured":"Weber KL, Doucet M, Price JE, Baker C, Kim SJ, Fidler IJ (2003) Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice. Cancer Res 63:2940\u20132947","journal-title":"Cancer Res"},{"key":"9390_CR28","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/jor.20063","volume":"24","author":"JH Waarsing","year":"2006","unstructured":"Waarsing JH, Day JS, Verhaar JA, Ederveen AG, Weinans H (2006) Bone loss dynamics result in trabecular alignment in aging and ovariectomized rats. J Orthop Res 24:926\u2013935","journal-title":"J Orthop Res"},{"key":"9390_CR29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0021-9290(03)00254-9","volume":"37","author":"A Nazarian","year":"2004","unstructured":"Nazarian A, M\u00fcller R (2004) Time-lapsed microstructural imaging of bone failure behavior. J Biomech 37:55\u201365","journal-title":"J Biomech"},{"key":"9390_CR30","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1210\/endo.138.10.5440","volume":"138","author":"M Sato","year":"1997","unstructured":"Sato M, Zeng GQ, Turner CH (1997) Biosynthetic human parathyroid hormone (1\u201334) effects on bone quality in aged ovariectomized rats. Endocrinology 138:4330\u20134337","journal-title":"Endocrinology"},{"key":"9390_CR31","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"key":"9390_CR32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(97)02342-8","volume":"350","author":"R Lindsay","year":"1997","unstructured":"Lindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V, Dempster D, Cosman F (1997) Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 350:550\u2013555","journal-title":"Lancet"},{"key":"9390_CR33","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00223-007-9056-7","volume":"81","author":"T Hashimoto","year":"2007","unstructured":"Hashimoto T, Shigetomi M, Ohno T, Matsunaga T, Muramatsu K, Tanaka H, Sugiyama T, Taguchi T (2007) Sequential treatment with intermittent low-dose human parathyroid hormone (1\u201334) and bisphosphonate enhances large-size skeletal reconstruction by vascularized bone transplantation. Calcif Tissue Int 81:232\u2013239","journal-title":"Calcif Tissue Int"},{"key":"9390_CR34","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00776-008-1311-x","volume":"14","author":"R Skripitz","year":"2009","unstructured":"Skripitz R, Johansson HR, Ulrich SD, Werner A, Aspenberg P (2009) Effect of alendronate and intermittent parathyroid hormone on implant fixation in ovariectomized rats. J Orthop Sci 14:138\u2013143","journal-title":"J Orthop Sci"},{"key":"9390_CR35","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1210\/en.2007-0229","volume":"148","author":"S Johnston","year":"2007","unstructured":"Johnston S, Andrews S, Shen V, Cosman F, Lindsay R, Dempster DW, Iida-Klein A (2007) The effects of combination of alendronate and human parathyroid hormone(1\u201334) on bone strength are synergistic in the lumbar vertebra and additive in the femur of C57BL\/6J mice. Endocrinology 148:4466\u20134474","journal-title":"Endocrinology"},{"key":"9390_CR36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11914-008-0003-y","volume":"6","author":"PD Miller","year":"2008","unstructured":"Miller PD (2008) Safety of parathyroid hormone for the treatment of osteoporosis. Curr Osteoporos Rep 6:12\u201316","journal-title":"Curr Osteoporos Rep"},{"key":"9390_CR37","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1359\/jbmr.2000.15.11.2211","volume":"15","author":"O Fromigue","year":"2000","unstructured":"Fromigue O, Lagneaux L, Body JJ (2000) Bisphosphonates induce breast cancer cell death in vitro. J Bone Miner Res 15:2211\u20132221","journal-title":"J Bone Miner Res"},{"key":"9390_CR38","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1054\/bjoc.2001.1727","volume":"84","author":"SP Jagdev","year":"2001","unstructured":"Jagdev SP, Coleman RE, Shipman CM, Rostami HA, Croucher PI (2001) The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel. Br J Cancer 84:1126\u20131134","journal-title":"Br J Cancer"},{"key":"9390_CR39","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1054\/bjoc.1999.1131","volume":"82","author":"SG Senaratne","year":"2000","unstructured":"Senaratne SG, Pirianov G, Mansi JL, Arnett TR, Colston KW (2000) Bisphosphonates induce apoptosis in human breast cancer cell lines. Br J Cancer 82:1459\u20131468","journal-title":"Br J Cancer"},{"key":"9390_CR40","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/8756-3282(95)00113-R","volume":"16","author":"PD Delmas","year":"1995","unstructured":"Delmas PD, Vergnaud P, Arlot ME, Pastoureau P, Meunier PJ, Nilssen MH (1995) The anabolic effect of human PTH(1\u201334) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate\u2014is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system? Bone 16:603\u2013610","journal-title":"Bone"},{"key":"9390_CR41","first-page":"53","volume":"1","author":"JA Gasser","year":"2000","unstructured":"Gasser JA, Kneissel M, Thomsen JS, Mosekilde L (2000) PTH and interactions with bisphosphonates. J Musculoskelet Neuronal Interact 1:53\u201356","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"9390_CR42","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1210\/en.2006-1475","volume":"148","author":"R Samadfam","year":"2007","unstructured":"Samadfam R, Xia Q, Goltzman D (2007) Pretreatment with anticatabolic agents blunts but does not eliminate the skeletal anabolic response to parathyroid hormone in oophorectomized mice. Endocrinology 148:2778\u20132787","journal-title":"Endocrinology"},{"key":"9390_CR43","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s11999-008-0241-4","volume":"466","author":"KA Mann","year":"2008","unstructured":"Mann KA, Lee J, Arrington SA, Damron TA, Allen MJ (2008) Predicting distal femur bone strength in a murine model of tumor osteolysis. Clin Orthop Relat Res 466:1271\u20131278","journal-title":"Clin Orthop Relat Res"},{"key":"9390_CR44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1359\/jbmr.2000.15.2.183","volume":"15","author":"KG Faulkner","year":"2000","unstructured":"Faulkner KG (2000) Bone matters: are density increases necessary to reduce fracture risk? J Bone Miner Res 15:183\u2013187","journal-title":"J Bone Miner Res"},{"key":"9390_CR45","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S8756-3282(03)00236-9","volume":"33","author":"RP Heaney","year":"2003","unstructured":"Heaney RP (2003) Is the paradigm shifting? Bone 33:457\u2013465","journal-title":"Bone"},{"key":"9390_CR46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S8756-3282(01)00491-4","volume":"29","author":"MC Meulen van der","year":"2001","unstructured":"van der Meulen MC, Jepsen KJ, Mikic B (2001) Understanding bone strength: size isn\u2019t everything. Bone 29:101\u2013104","journal-title":"Bone"},{"key":"9390_CR47","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.bone.2006.06.016","volume":"39","author":"G Bevill","year":"2006","unstructured":"Bevill G, Eswaran SK, Gupta A, Papadopoulos P, Keaveny TM (2006) Influence of bone volume fraction and architecture on computed large-deformation failure mechanisms in human trabecular bone. Bone 39:1218\u20131225","journal-title":"Bone"},{"key":"9390_CR48","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1007\/BF01673396","volume":"53 Suppl 1","author":"BD Snyder","year":"1993","unstructured":"Snyder BD, Piazza S, Edwards WT, Hayes WC (1993) Role of trabecular morphology in the etiology of age-related vertebral fractures. Calcif Tissue Int 53 Suppl 1:S14\u2013S22","journal-title":"Calcif Tissue Int"},{"key":"9390_CR49","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02008077","volume":"1","author":"GH Bell","year":"1967","unstructured":"Bell GH, Dunbar O, Beck JS, Gibb A (1967) Variations in strength of vertebrae with age and their relation to osteoporosis. Calcif Tissue Res 1:75\u201386","journal-title":"Calcif Tissue Res"},{"key":"9390_CR50","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00003086-198602000-00036","volume":"203","author":"JS Keene","year":"1986","unstructured":"Keene JS, Sellinger DS, McBeath AA, Engber WD (1986) Metastatic breast cancer in the femur. A search for the lesion at risk of fracture. Clin Orthop Relat Res 203:282\u2013288","journal-title":"Clin Orthop Relat Res"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-010-9390-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-010-9390-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-010-9390-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T20:52:38Z","timestamp":1635540758000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-010-9390-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,20]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["9390"],"URL":"https:\/\/doi.org\/10.1007\/s00223-010-9390-z","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,20]]}}}